Table 1. Embolization procedures and associated femoral head ischemia.
Left Hip | Right Hip | ||||||||
---|---|---|---|---|---|---|---|---|---|
FH Ischemia on CE-MRI (% Volume) |
FH Ischemia on CE-MRI (% Volume) | ||||||||
Pig | Age Mass Sex | Targeted Artery | Embolic agent | Post-Op | 7-days | Targeted Artery | Embolic agent | Post-Op | 7-days |
1 | 5 wk 13.7 kg Male |
DMFCA | 6.5 ml of embolic particles | 30% | 0% | DMFCA | 8.5 ml of embolic particles | 90% | 20% |
2 | 6 wk 12.2 kg Male |
DMFCA | 6.0 ml of embolic particles | 50% | 0% | DMFCA | 0.5 ml of diluted Lipiodol® | 10% | 0% |
3 | 5 wk 10.0 kg Male |
DMFCA | 4.5 ml of embolic particles + balloon catheter | 80% | N/A | DMFCA | 4 ml of diluted Lipiodol® | 0% | N/A |
4 | 4 wk 10.0 kg M |
DMFCA | 6 ml of embolic particles | 50% | 0% | DMFCA | 6 ml of embolic particles | 50% | 20% |
5 | 5 wk 13.8 kg Male |
DMFCA | 1 ml of diluted Truefill™ + embolic particles | N/A | 0% | LFCA + DMFCA | 1 ml of diluted Truefill™ + embolic particles | N/A | 0% |
6 | 6 wk 11.5 kg Male |
DMFCA + AMFCA | 20 ml of embolic particles + two coils1,2 | 0% | DMFCA + AMFCA | 20 ml of embolic particles + one coil1 | 0% | ||
7 | 6 wk 14.6 kg Female |
DMFCA + AMFCA (failed attempt) | 20 ml of embolic particles + coil3 | 0% | DMFCA + AMFCA (failed attempt) | 20 ml of embolic particles + coil4 | 0% | ||
8 | 12 wk 22.8 kg Male |
DMFCA + AMFCA | 4.5 ml of embolic particles + 1 coil3 | 10% | DMFCA + AMFCA | 3 ml of embolic particles + 1 coil3 | 20% |
Micro-coil Details: 1 Helix ev3 Conscerto coil (2 mm x 4 cm; NV-2–4-HELIX), 2 3D ev3 Concerto coil (2 mm x 2 cm; PV-2–2-3D), 3 Helix ev3 Concerto coil (2 mm x 6 cm; NV-2–6-HELIX), 4 Helix ev3 Conscerto coil (2 mm x 8 cm; NV-2–8-HELIX). DMFCA = Deep Medial Femoral Circumflex Artery; LFCA = Lateral Femoral Circumflex artery, AMFCA = Acetabular Medial Femoral Circumflex Artery.